Lecanemab treatment for Alzheimer's Disease of varying severities and associated plasma biomarkers monitoring: A multi-center real-world study in China.

Alzheimers Dement · 2025 · PMC12511950 · PMID 41070709

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among plasma biomarkers, both p‐tau181 and GFAP exhibited a downward trend, but the changes did not reach statistical significance (Table S10 ). 3.6.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.